Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
586
datasets available to search
ShareScore release 0.9.0
Dataset results
586 results for “allogeneic stem cell transplant”
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
ClinicalTrials.gov study NCT03367546. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Music During Allogeneic Stem Cell Transplant Hospitalization
ClinicalTrials.gov study NCT06679530. IPD Sharing: NO. Countries: 1. Publications: 0.
Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT05727917. IPD Sharing: NO. Countries: 1. Publications: 0.
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00355407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients
ClinicalTrials.gov study NCT00010361. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03850418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00057005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT03207191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma
ClinicalTrials.gov study NCT01636388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS
ClinicalTrials.gov study NCT06247917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia
ClinicalTrials.gov study NCT01020539. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults
ClinicalTrials.gov study NCT07048730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT06395220. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01758328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma
ClinicalTrials.gov study NCT00504634. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multimodal Intervention in Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00427115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
ClinicalTrials.gov study NCT00881556. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
ClinicalTrials.gov study NCT06856226. IPD Sharing: YES. Countries: 1. Publications: 0.
Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.
ClinicalTrials.gov study NCT02017457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00563589. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.